The Nervous System Part II: Trauma, Vascular Diseases, and Degenerative Disorders

Traumatic Carotid Artery Injury (CAI)

• Overview: Carotid artery injury (also known as blunt or penetrating carotid artery injury) involves damage to the vessels that run through the neck and provide the majority of blood supply to the brain. Because these vessels are critical, injuries are life-threatening and can lead to ischemic stroke, hemorrhage, or death if not identified and treated promptly.

• Types and Mechanisms:

  • Blunt Carotid Artery Injury: The most common form. It is typically caused by non-penetrating trauma.

    • Motor Vehicle Collisions (MVCs): Account for most cases due to sudden neck hyperextension, hyperflexion, or rotation.

    • Other Causes: Direct blows to the neck, seat belt injuries, falls, and sports injuries.

  • Penetrating Carotid Artery Injury: Caused by direct disruption of the vessel.

    • Sources: Stab wounds, gunshot wounds, and penetrating neck trauma.

• Forms of Injury: Damage can manifest as an intimal tear (inner layer tear), dissection, pseudoaneurysm, occlusion, transection, or rupture.

• Clinical Presentation:

  • Early Symptoms: Often subtle or absent (initially asymptomatic in up to $50\%$ of patients).

    • Symptoms include neck pain, headache, and bruit (audible turbulence heard with a stethoscope).

    • Horner Syndrome: A classic sign of dissection, characterized by the triad of ptosis (drooping eyelid), meiosis (constricted pupil), and anhidrosis (lack of sweating).

  • Delayed/Severe Symptoms: Ischemic stroke, hemiparesis (weakness on one side), aphasia (speech impairment), vision loss, altered mental status, and seizures.

• Diagnosis:

  • Computed Tomography Angiography (CTA): The modality of choice for diagnosis. It is quick, highly sensitive, and effective at identifying dissections, occlusions, and pseudoaneurysms.

  • MRI/MRA: Useful for follow-up and assessing brain ischemia.

  • Digital Subtraction Angiography: Considered the gold standard but is invasive and used selectively.

• Screening High-Risk Patients: Patients should be screened if they present with cervical spine fractures, skull base fractures, severe facial fractures, a "neck seat belt sign" (mark across the neck), hanging/strangulation injuries, or unexplained neurologic deficits.

• Treatment and Management:

  • Medical Management: The mainstay in most cases. Focuses on antithrombotic therapy or antiplatelet agents to significantly reduce stroke risks.

  • Endovascular/Surgical Intervention: Indicated for expanding pseudoaneurysms, active bleeding, vessel rupture, or failure of medical therapy. Options include stenting and surgical repair.

• Prognosis: Highly dependent on early recognition. Without treatment, the risk of stroke is up to $60\%$, but this is dramatically reduced with early intervention.

Facial Fractures

• Description: Breaks in the facial bones resulting from blunt or penetrating trauma (MVCs, assaults, falls, sports). These often occur alongside head, cervical spine, or ocular injuries.

• Nasal Bone Fracture: The most common type of facial fracture.

  • Manifestations: Nasal pain, swelling, deformity, epistaxis (nosebleed), and crepitus (crackling sound under the skin).

  • Major Complication: Septal hematoma. This is a medical emergency because it can lead to cartilage necrosis.

• Zygomaticomaxillary Complex (ZMC) Fracture (Tripod Fracture):

  • Involvement: Zygomatic arch, maxilla, and the orbital floor or lateral wall.

  • Findings: Flattened cheek, periorbital swelling, infraorbital nerve numbness, and diplopia (double vision).

  • Trismus: A condition where the patient has restricted or painful mouth opening due to jaw muscle spasm or dysfunction.

• Orbital Floor (Blowout) Fracture:

  • Mechanism: Caused by a direct blow to the front of the eye (orbit).

  • Findings: Double vision (especially with upward gaze), enophthalmos (sunken eyes), restricted eye movement, and risk of extraocular muscle entrapment.

• Maxillary (Le Fort) Fractures: Severe injuries involving bilateral and horizontal fractures of the maxilla.

  • Le Fort I: A horizontal fracture above the upper teeth, causing a "floating palate."

  • Le Fort II: A pyramidal fracture extending from the nasal bridge to the maxilla and involving the orbit.

  • Le Fort III: The most severe type; involves complete craniofacial dysfunction where the face is separated from the skull. High risk of Cerebrospinal Fluid (CSF) leak and airway compromise.

• Mandibular Fracture: The second most common facial fracture.

  • Findings: Jaw pain, trismus, lower lip numbness, and step-off deformity.

  • Malocclusion: Misalignment of the teeth or improper relationship between the upper and lower dental arches when the jaw is closed.

• Clinical Management:

  • Trauma Priority: ABCs (Airway, Breathing, Circulation). Airway compromise is a major concern.

  • Imaging: Thin-slice CT with $3D$ reconstruction is the gold standard for defining fracture patterns.

  • Treatment: Conservative (soft diet, analgesia) for non-displaced fractures; surgical repair (Open Reduction and Internal Fixation or ORIF) using plates, screws, and wires for displaced or functional fractures.

Vascular Diseases of the Central Nervous System (CNS)

• Cerebrovascular Accident (CVA/Stroke): Sudden development of a focal neurologic deficit. It is a leading cause of death and long-term disability.

• Ischemic Stroke ($80 \text{ to } 85\%$ of cases):

  • Cause: Reduced or blocked blood flow to the brain, typically due to thrombosis or embolism (frequently from atherosclerosis of the carotid arteries or cardiac thrombi from atrial fibrillation).

  • Transient Ischemic Attack (TIA): A temporary interruption of blood flow. Symptoms usually resolve within $24 \text{ hours}$ (often minutes). It causes no permanent damage but serves as a warning for future strokes.

• Hemorrhagic Stroke:

  • Intracerebral Hemorrhage (ICH): Bleeding within the brain tissue, most commonly caused by chronic hypertension or cerebral amyloid angiopathy.

  • Subarachnoid Hemorrhage (SAH): Bleeding into the subarachnoid space, usually due to a ruptured berry (saccular) aneurysm. Characterized by a sudden "thunderclap headache."

• Risk Factors:

  • Nonmodifiable: Age, sex, family history/genetics, and prior TIA/stroke.

  • Modifiable: Hypertension (most important), diabetes, hyperlipidemia (leads to atherosclerosis), smoking, obesity, and sedentary lifestyle.

• Symptom Recognition (FAST):

  • F: Facial drooping.

  • A: Arm weakness or numbness (typically one side).

  • S: Speech (slurred or difficult).

  • T: Time to call emergency services immediately.

• Diagnostics: Non-contrast CT is the first modality to distinguish between ischemic and hemorrhagic. MRI with Diffusion-Weighted Imaging (DWI) is more sensitive for early ischemia. Ultrasound Carotid Duplex is the initial screening for carotid artery atherosclerosis.

• Management:

  • Acute Ischemic: IV Thrombolysis (within a specific time window) or Mechanical Thrombectomy (catheter-based removal of the clot).

  • Acute Hemorrhagic: Blood pressure control and reverse anticoagulation (neutralizing blood thinners to stop active bleeding).

Multiple Sclerosis (MS)

• Definition: A chronic autoimmune disease of the CNS affecting the brain, spinal cord, and optic nerves.

• Pathology: Immune system attacks the myelin sheath (the protective axon covering that ensures rapid conduction). This leads to demyelination, inflammation, axonal damage, and the formation of plaques/lesions.

• Demographics: Usually diagnosed between ages $20 \text{ and } 40$. Women are affected $2 \text{ to } 3$ times more than men.

• Pattern of Damage: Dissemination in Time and Space (damage occurs in different locations and at different time points, showing the disease is recurrent).

• Clinical Presentation: Symptoms wax and wane (relapse and remission). Includes visual deficits, sensory changes, speech issues, and ataxia (impaired coordination of voluntary movements).

• Diagnosis: MRI is the gold standard, demonstrating white matter lesions or plaques.

• Treatment: No cure. High-dose IV corticosteroids manage inflammation during relapses; disease-modifying therapies (DMTs) help reduce relay frequency and slow progression.

Epilepsy and Convulsive Disorders

• Definitions:

  • Seizure: A single sudden burst of abnormal electrical activity in the brain.

  • Epilepsy: A chronic disorder characterized by recurrent ($2$ or more), unprovoked seizures occurring more than $24 \text{ hours}$ apart.

• Types of Seizures:

  • Focal (Partial) Seizure: Begins in one area of the brain.

    • Focal Aware: Consciousness is preserved.

    • Focal Impaired Awareness: Consciousness is altered. May involve automatisms (lip smacking, picking movements).

  • Generalized Seizure: Involves both hemispheres from the start.

    • Tonic-Clonic (Grand Mal): Tonic phase (body stiffness, $10-20 \text{ seconds}$) followed by Clonic phase (rhythmic jerking/convulsions, $30-90 \text{ seconds}$). Followed by a postictal state (confusion, fatigue).

    • Absence (Petit Mal): Common in children ($4-10 \text{ years}$). Brief staring spells ($5-10 \text{ seconds}$) with immediate recovery and no postictal confusion.

    • Myoclonic: Sudden, brief, shock-like involuntary muscle jerks.

    • Atonic ("Drop Attack"): Sudden loss of muscle tone causing the person to go limp and collapse. High risk of injury.

• Diagnosis: Electroencephalogram (EEG) is the gold standard for identifying epileptiform activity.

• Treatment: First-line is anti-seizure medication. For drug-resistant cases, surgery, vagus nerve stimulation, or a ketogenic diet (especially in children) may be used.

Neurodegenerative Diseases

• Normal Aging vs. Disease: In normal aging, intelligence and long-term memory are preserved, though processing speed and reflexes may slow. Loss of function or severe memory loss indicates pathology (dementia).

• Alzheimer Disease:

  • Description: Most common cause of dementia. Characterized by a gradual decline in memory and cognition.

  • Abnormalities: Amyloid B plaques (extracellular) and Neurofibrillary tangles of tau protein (intracellular). These cause brain atrophy, especially in the hippocampus.

  • Progression: From short-term memory loss (mild) to loss of motor function, inability to swallow, and total dependence (severe).

• Huntington Disease:

  • Description: An inherited progressive disorder caused by a mutation in the HTT gene, leading to abnormal protein accumulation.

  • Target: Damages neurons in the caudate nucleus and putamen.

  • Symptoms: Core symptom is Chorea (involuntary, dance-like movements). Also includes dystonia (abnormal postures), psychiatric symptoms (depression, psychosis), and cognitive decline.

• Parkinson Disease (Shaking Palsy):

  • Description: Loss of dopaminergic neurons in the substantia nigra. Symptoms appear when $60 \text{ to } 80\%$ of these neurons are lost.

  • Motor Symptoms: Bradykinesia (slowness), resting tremor ("pill rolling"), and rigidity (cogwheel or lead pipe). Postural instability and shuffling gait.

  • Non-motor Symptoms: Loss of smell, REM sleep behavior disorder (acting out dreams), and orthostatic hypotension.

  • Diagnosis/Treatment: Diagnosed clinically; response to Levodopa (L-Dopa) supports diagnosis. DAT scan (SPECT imaging) measures dopamine transporter activity. Deep Brain Stimulation (DBS) is a surgical option.

• Cerebral/Cerebellar Atrophy:

  • Description: Shrinkage of neurons in the cerebellum, which controls coordination and balance.

  • Causes: Alcohol use (toxic effect and Thiamine/B1 deficiency), genetics (Friedreich ataxia), or prion disease (Creutzfeldt-Jakob disease – a rapidly fatal "brain-eating" disease).

  • Signs: Ataxia and nystagmus (rapid involuntary eye movements).

• Amyotrophic Lateral Sclerosis (ALS / Lou Gehrig Disease):

  • Description: Progressive motor neuron disease (affects both upper and lower neurons).

  • Signs: Muscle weakness, atrophy, fasciculations (twitching), and the Babinski sign (abnormal upward toe extension in adults).

  • Prognosis: Fatal disease; leading cause of death is respiratory failure, usually within $3 \text{ to } 5 \text{ years}$.

Hydrocephalus

• Definition: Abnormal buildup of CSF in brain ventricles, leading to dilatation and pressure on brain tissue.

• Types:

  • Communicating: Flow is open but absorption is impaired or production is excessive.

  • Non-communicating (Obstructive): Physical blockage (e.g., aqueductal stenosis).

  • Normal Pressure Hydrocephalus (NPH): Seen in older adults. Triad: gait disturbance ("magnetic gait" where feet seem glued to floor), urinary incontinence, and cognitive decline.

  • Hydrocephalus ex vacuo: Enlargement due to brain shrinkage (atrophy), not pressure.

• Management: Usually requires a Ventriculoperitoneal (VP) Shunt to divert fluid to the abdomen for reabsorption.

Sinusitis (Rhinosinusitis)

• Description: Inflammation of the sinus linings. Usually triggered by the common cold (viral) but can be bacterial if symptoms last > 10 \text{ days}.

• Signs: Facial pressure, yellow/green mucus, and tooth pain (upper teeth).

• Management: Most cases are viral and do not require antibiotics. Treatment focuses on rest, hydration, and nasal saline rinses.